Site navigation

Navigation

Photo-dynamic therapy for early oesophageal cancer

 
Guidance issued
 
Number: IPG200

Summary

The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on photo-dynamic therapy for early oesophageal cancer.

Description

Oesophageal cancer usually originates in the lining of the oesophagus and can develop in the upper, middle, or lower section of the organ. Photodynamic therapy uses light to kill cancer cells. The patients takes a drug that makes cancerous cells sensitive to light. Then the doctor shines a very bright light onto the oesophagous which activates the drug and kills the cells.

OPCS code:

Details

Arrangement:
Special
Topic area:
Cancer
Digestive system
Therapeutic procedures
Specialty:
Clinical oncology
Gastroenterology
Medical oncology
Specialist advice has been sought from:

Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland

British Society of Gastroenterology

British Association of Surgical Oncology

Date notified to NICE:
08 April 2005
Provisional consultation date:
Autumn 2006
Guidance issue date:
13 December 2006

Contact details:

Project manager (for general enquiries or comments)
(for general enquiries or comments)
Ben Doak
Technical lead
(for procedure specific enquiries or comments)
Steven Barnes
ip@nice.org.uk
Contact Address:

Interventional Procedures Programme
National Institute for Health and Clinical Excellence
MidCity Place
71 High Holborn
London
WC1V 6NA

Links: